TrialThe Journal of clinical investigation2019

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.

Parisa Malekzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.